Recruiting NA INTERVENTIONAL 2-arm NCT06572839

Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone

A Randomized Controlled Multicenter Trial, Examining the Effect of Amnio-Maxx on the Healing Rate of Chronic Diabetic Foot Ulcers

Sponsor: Capsicure, LLC

Conditions Diabetic Foot Ulcer

Interventions Amnio-Maxx

Updated 4 times since 2024 Last updated: Apr 28, 2025 Started: Oct 25, 2024 Primary completion: Oct 31, 2025 Completion: Oct 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A NA clinical study on Diabetic Foot Ulcer, this trial is actively recruiting participants. The trial is conducted by Capsicure, LLC and has accumulated 4 data snapshots since 2024. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

4 versions recorded

May 2025 — Present [monthly]

Recruiting NA
Apr 2025 — May 2025 [monthly]

Recruiting NA
Mar 2025 — Apr 2025 [monthly]

Recruiting NA

Status: Not Yet Recruiting → Recruiting
Sep 2024 — Mar 2025 [monthly]

Not Yet Recruiting NA

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Capsicure, LLC

Data source: Capsicure, LLC

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Allentown, United States , Athens, United States , Coral Gables, United States , East Patchogue, United States , Hammond, United States , Hialeah, United States , Houston, United States , Jacksonville, United States , Miami, United States , Oradell, United States and 2 more locations